Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599803 · ClinicalTrials.gov registry record · NA
Baseline Sleep Apnea Study #2
A NA study, sponsored by Verily Life Sciences.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
NCT04599803 is a NA study that has completed, run by Verily Life Sciences. The registered enrollment target is 187 participants.
The verdict
NCT04599803, a NA study, has completed, sponsored by Verily Life Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
Study Summary
This is a single group, unblinded, prospective clinical study. This study seeks to understand patient diagnostic and treatment journey and positive airway pressure (PAP) therapy compliance for Verily Sleep Apnea (VSA) program/app users. Participants will enroll remotely and may undergo a home sleep test (HST). Upon confirmation of obstructive sleep apnea (OSA) and prescription of PAP therapy, the participant will begin using the VSA app to supplement PAP treatment. After 90 days of active participation, the participant will be given instructions for follow-up care, as indicated.
Interventions
- DEVICE Verily Sleep Apnea (VSA) Program/App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2020-07-08 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04599803
The ClinicalTrials.gov registry entry for NCT04599803 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Verily Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Verily Sleep Apnea (VSA) Program/App is the first listed.
NCT04599803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04599803 about?
NCT04599803 is a clinical study titled "Baseline Sleep Apnea Study #2". This is a single group, unblinded, prospective clinical study. This study seeks to understand patient diagnostic and treatment journey and positive airway pressure (PAP) therapy compliance for Verily Sleep Apnea (VSA) program/app users. Participants will enroll remotely and may undergo a home sleep ...
What is the current status of trial NCT04599803?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2020-07-08. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT04599803?
The interventions under investigation include: Verily Sleep Apnea (VSA) Program/App (DEVICE).
Who is sponsoring clinical trial NCT04599803?
This trial is sponsored by Verily Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.